Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prenatal diagnosis in Norway

K Berg1

  • 1Institute of Medical Genetics, University of Oslo, Norway.

European Journal of Human Genetics : EJHG
|January 1, 1997
PubMed
Summary

Prenatal diagnosis (PND) in Norway is free but limited, impacting fewer births than in other Western European nations. While effective for autosomal chromosome anomalies, its scope is restricted by political decisions, not technology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

Cancer·1997
Same author

Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.

Cancer research·1997
Same author

Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart.

Investigative radiology·1997
Same author

Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia.

British journal of obstetrics and gynaecology·1997
Same author

Lysosomes and microtubules as targets for photochemotherapy of cancer.

Photochemistry and photobiology·1997
Same author

Molecular genetics of familial hypercholesterolaemia in Norway.

Journal of internal medicine·1997

Area of Science:

  • Medical Genetics
  • Public Health Policy
  • Reproductive Medicine

Background:

  • Prenatal diagnosis (PND) for genetic disorders is a publicly funded service in Norway.
  • The volume of PND examinations in Norway is notably lower compared to other Western European countries.
  • Access to PND for advanced maternal age is restricted to women 38 years or older at delivery.

Purpose of the Study:

  • To evaluate the scope and impact of prenatal diagnosis services in Norway.
  • To identify factors limiting the utilization of prenatal diagnosis.
  • To assess the effectiveness of PND in reducing births with specific genetic anomalies.

Main Methods:

  • Analysis of national data on prenatal diagnosis utilization and outcomes.
  • Review of policy guidelines and potential influencing factors on PND service volume.
  • Comparison of PND rates and outcomes with other Western European countries.

Main Results:

  • Norway offers cost-free prenatal diagnosis, yet performs fewer examinations than comparable nations.
  • Adequate technology and expertise for PND are available.
  • Political decisions, potentially influenced by specific groups, appear to limit the extent of PND services.
  • PND has successfully reduced births with autosomal chromosome anomalies.
  • The impact of PND on other types of genetic disorders is minimal.

Conclusions:

  • Prenatal diagnosis in Norway is technically feasible and politically restricted, impacting its volume.
  • The service has demonstrated effectiveness in reducing specific chromosomal abnormalities.
  • Policy and societal factors significantly influence the accessibility and scope of PND services.

Related Experiment Videos